Capital International Investors 13D/13G Filings for Sage Therapeutics, Inc. (SAGE)

Capital International Investors 13D and 13G filings for Sage Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
4:22 pm
Sale
2021-02-16 13G Sage Therapeutics, Inc.
SAGE
Capital International Investors 87,336
0.200%
-4,035,901decrease
(-97.88%)
Filing